<DOC>
	<DOC>NCT01156948</DOC>
	<brief_summary>To compare the impact of 400-microgram self-administered vaginal versus self-administered oral misoprostol at home on preoperative cervical ripening in nulliparous women prior to outpatient hysteroscopy.</brief_summary>
	<brief_title>Misoprostol For Nulliparous Women Before Hysteroscopy</brief_title>
	<detailed_description>There is no consensus on the effect of misoprostol on cervical ripening for nulliparous women. The aim of the study is to compare the impact of 400-microgram self-administered vaginal versus self-administered oral misoprostol at home on preoperative cervical ripening in nulliparous women prior to outpatient hysteroscopy.</detailed_description>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>nulliparous women who are referred to outpatient hysteroscopy and who have given informed consent will be eligible for study recruitment. women with a known allergy to misoprostol.</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>misoprostol</keyword>
	<keyword>nulliparous</keyword>
	<keyword>hysteroscopy</keyword>
</DOC>